edoc

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis : a multi-arm, multi-stage randomised controlled trial

Boeree, M. J. and Heinrich, N. and Aarnoutse, R. and Diacon, A. H. and Dawson, R. and Rehal, S. and Kibiki, G. S. and Churchyard, G. and Sanne, I. and Ntinginya, N. E. and Minja, L. T. and Hunt, R. D. and Charalambous, S. and Hanekom, M. and Semvua, H. and Mpagama, S. G. and Manyama, C. and Mtafya, B. and Reither, K. and Wallis, R. S. and Venter, A. and Narunsky, K. and Mekota, A. and Henne, S. and Colbers, A. and van Balen, G. P. and Gillespie, S. H. and Phillips, P. P. J. and Hoelscher, M.. (2017) High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis : a multi-arm, multi-stage randomised controlled trial. The Lancet infectious diseases, 17 (1). pp. 39-49.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/54365/

Downloads: Statistics Overview


Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Medicine > Clinical Research (Reither)
UniBasel Contributors:Reither, Klaus
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Elsevier
ISSN:1473-3099
Note:Publication type according to Uni Basel Research Database: Journal article
Last Modified:14 Jun 2017 13:52
Deposited On:14 Jun 2017 13:52

Repository Staff Only: item control page